Update on the Clinical Utility of an RNA Interference-Based Treatment: Focus on Patisiran

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s87945
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

An Update on the Clinical Utility of Extracorporeal Photopheresis in the Treatment of Graft-Versus-Host Disease

International Journal of Clinical Transfusion Medicine
2017English

An Update on the Clinical Utility of the Children's Post-Traumatic Cognitions Inventory

Journal of Traumatic Stress
PsychiatryClinical PsychologyMental Health
2016English

An Update on Candida Tropicalis Based on Basic and Clinical Approaches

Frontiers in Microbiology
Microbiology
2017English

Pediatric Depression: An Evidence-Based Update on Treatment Interventions

Current Psychiatry Reports
PsychiatryMental Health
2013English

Methamphetamine: An Update on Epidemiology, Pharmacology, Clinical Phenomenology, and Treatment Literature

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2014English

Update on Hereditary Colorectal Cancer: Improving the Clinical Utility of Multigene Panel Testing

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Update and Developments in the Treatment of Glioblastoma Multiforme &Ndash; Focus on Bevacizumab

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2010English

Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis

Journal of Clinical Pharmacology
Pharmacology
2019English

An Update on Clinical Oncology for the Non-Oncologist

Einstein (São Paulo, Brazil)
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy